Major Drivers Propelling the Growth oh thePreimplantation Genetic Testing Market Forward: Growth In IVF Procedures Driving Preimplantation Genetic Testing Market Expansion
Discover trends, market shifts, and competitive outlooks for the preimplantation genetic testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Key Projections for the CAGR of the Preimplantation Genetic Testing Market Size From 2025 to 2034?
Rapid growth has been observed in the preimplantation genetic testing market size in the past few years. The market is set to expand from $0.83 billion in 2024 to $0.92 billion in 2025, marking an impressive compound annual growth rate (CAGR) of 11.6%. The upswing in this historic phase is chiefly due to the rising instances of genetic disorders, enhanced awareness about genetic testing, the proliferation of prenatal testing alternatives, heightened demand for customized medicine, and an escalated emphasis on preventive healthcare.
The market size for preimplantation genetic testing is projected to experience significant growth in the coming years, with a predicted valuation of $1.41 billion by 2029, charting a compound annual growth rate (CAGR) of 11.2%. This surge in the projected period is due to various factors such as an increase in the number of fertility clinics, expansion in genetic counselling services, a rise in advanced maternal age cases, greater access to hi-tech genetic testing platforms, and broadening scope for PGT applications. Key trends for this forecast period include the uptake of cutting-edge sequencing technologies, the introduction of comprehensive genetic panels, progress in non-invasive test methodologies, advancements in embryo cultivating systems, and forward strides in genetic editing technologies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20596&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Preimplantation Genetic Testing Market?
The surge in in vitro fertilization (IVF) procedures is predicted to fuel the expansion of the preimplantation genetic testing market. IVF involves the external fertilization of an egg with sperm to create an embryo, which is then transferred into the uterus. The rise in IVF procedures can be attributed to enhancements in reproductive technology, escalating infertility rates, and increased public consciousness. The upward trend in IVF procedures is enhancing the preimplantation genetic testing market by amplifying the requirement for genetic examination of embryos prior to implantation. For example, the Society for Assisted Reproductive Technology, a US-based entity, reported that in 2022, 91,771 babies were conceived through in vitro fertilization (IVF). Hence, the growth in IVF procedures is stimulating the preimplantation genetic testing market.
Which Key Market Segments Comprise the Preimplantation Genetic Testing Market and Drive Its Revenue Growth?
The preimplantation genetic testing market covered in this report is segmented –
1) By Procedure: Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis
2) By Product: Reagents And Consumables, Instruments, Software
3) By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In Situ Hybridization (FISH), Other Technologies
4) By Application: Chromosomal Abnormalities, Aneuploidy Screening, X-Linked Diseases, Embryo Testing, Human Leukocyte Antigen (HLA) Typing, Other Applications
5) By End User: Hospitals, Fertility Centers, Diagnostic Centers, Research Centers And Academic Labs
Subsegments:
1) By Preimplantation Genetic Screening (PGS): Array Comparative Genomic Hybridization (aCGH), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
2) By Preimplantation Genetic Diagnosis (PGD): Monogenic Disorders Testing, Chromosomal Abnormalities Testing, HLA Typing for Stem Cell Transplantation
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20596&type=smp
Which Areas Are Leading Regions in the Preimplantation Genetic Testing Market Expansion Across the Globe?
North America was the largest region in the preimplantation genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preimplantation genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing the Preimplantation Genetic Testing Industry Evolution?
Major players in the preimplantation genetic testing market are innovating advanced next-generation sequencing (NGS) solutions to improve precision, productivity, and pace in genetic screening, which allows thorough examination and insightful decisions for future parents. Next-generation sequencing (NGS) capabilities hasten genetic studies with quick, high-throughput investigation of DNA and RNA. They offer in-depth knowledge of genetic alterations and gene activity, boosting precision and facilitating personalized healthcare. For example, in July 2023 Thermo Fisher Scientific, a biotech firm based in the US, introduced the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit. These advanced next-generation sequencing tools were created to boost IVF and ICSI studies. These tests simplify workflows from specimen handling to aneuploidy scrutiny with state-of-the-art technology on the ion torrent genexus integrated sequencer. This marks a substantial progress in the preimplantation genetic testing market by optimizing embryo examination and enhancing success probabilities in assisted reproduction techniques.
View the full report here:
How Is the Preimplantation Genetic Testing Market Conceptually Defined?
Preimplantation genetic testing (PGT) is a procedure that examines embryos for genetic issues before they are implanted during in vitro fertilization (IVF). It helps identify genetic abnormalities to avoid certain inherited conditions, improving the odds of a successful pregnancy. PGT enhances the likelihood of successful implantation, lowers the risk of miscarriage, and prevents genetic diseases.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20596
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
